Debatin KM - Search Results

1

MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.

Boldrin E, Gaffo E, Niedermayer A, Boer JM, Zimmermann M, Weichenhan D, Claus R, Münch V, Sun Q, Enzenmüller S, Seyfried F, Demir S, Zinngrebe J, Cario G, Schrappe M, Den Boer ML, Plass C, Debatin KM, Te Kronnie G, Bortoluzzi S, Meyer LH. Boldrin E, et al. Among authors: debatin km. Blood. 2021 Nov 18;138(20):1953-1965. doi: 10.1182/blood.2020007591. Blood. 2021. PMID: 34098582 Free article.

2

Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias.

Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH. Knipping E, et al. Among authors: debatin km. Blood. 1995 Mar 15;85(6):1562-9. Blood. 1995. PMID: 7534137 Free article.

3

APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia.

Debatin KM, Goldman CK, Waldmann TA, Krammer PH. Debatin KM, et al. Blood. 1993 Jun 1;81(11):2972-7. Blood. 1993. PMID: 7684622 Free article.

4

Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).

Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM. Los M, et al. Among authors: debatin km. Blood. 1997 Oct 15;90(8):3118-29. Blood. 1997. PMID: 9376593 Free article.

5

CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.

Beltinger C, Kurz E, Böhler T, Schrappe M, Ludwig WD, Debatin KM. Beltinger C, et al. Among authors: debatin km. Blood. 1998 May 15;91(10):3943-51. Blood. 1998. PMID: 9573033 Free article.

6

Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.

Beltinger C, Böhler T, Karawajew L, Ludwig WD, Schrappe M, Debatin KM. Beltinger C, et al. Among authors: debatin km. Br J Haematol. 1998 Aug;102(3):722-8. doi: 10.1046/j.1365-2141.1998.00827.x. Br J Haematol. 1998. PMID: 9722299 Free article.

7

[The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].

Beltinger C, Böhler T, Schrappe M, Ludwig WD, Debatin KM. Beltinger C, et al. Among authors: debatin km. Klin Padiatr. 1998 Jul-Aug;210(4):153-8. doi: 10.1055/s-2008-1043871. Klin Padiatr. 1998. PMID: 9743945 Review. German.

8

Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.

Fulda S, Strauss G, Meyer E, Debatin KM. Fulda S, et al. Among authors: debatin km. Blood. 2000 Jan 1;95(1):301-8. Blood. 2000. PMID: 10607716 Free article.

9

Müller SM, Kohn T, Schulz AS, Debatin KM, Friedrich W. Müller SM, et al. Among authors: debatin km. Blood. 2000 Dec 15;96(13):4344-9. Blood. 2000. PMID: 11110711 Free article.

10

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy.

Stahnke K, Fulda S, Friesen C, Strauss G, Debatin KM. Stahnke K, et al. Among authors: debatin km. Blood. 2001 Nov 15;98(10):3066-73. doi: 10.1182/blood.v98.10.3066. Blood. 2001. PMID: 11698292 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters